Allergy and Asthma: Small molecule approaches

Research output: Chapter in Book/Report/Conference proceedingChapter


Current therapies for asthma and allergy are aimed at controlling disease symptoms. For most asthmatics, inhaled anti-inflammatory therapy is effective, but a subset of patients remains symptomatic despite optimal treatment creating a clear unmet medical need. Although considered a less-serious condition than asthma, allergic diseases are common and considerably impact on the quality of life of affected individuals. Innovative disease-modifying therapeutics are needed for both allergy and asthma. Biopharmaceutical approaches may identify small molecules that target key cells and mediators that drive the inflammatory responses that underlie the pathogenesis of allergy and asthma.
Original languageEnglish
Title of host publicationWiley Encyclopaedia of Chemical Biology
EditorsT.P. Begley
Number of pages8
ISBN (Electronic)978-0470048672
ISBN (Print)0471754773, 978-0471754770
Publication statusPublished - 29 Jan 2008


Dive into the research topics of 'Allergy and Asthma: Small molecule approaches'. Together they form a unique fingerprint.

Cite this